Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00889538 · ClinicalTrials.gov registry record · NA

Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems

A NA study, sponsored by University of Louisville.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT00889538 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00889538, a NA study, has completed, sponsored by University of Louisville.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

This is a double-blind, placebo-controlled crossover study to evaluate the safety and efficacy of glutathione alone or glutathione, vitamin C and NAC treatment in children with autism who also have severe behavior problems. The investigators hypothesis is that children with autism will show improvement in both learning capabilities and behavior with either glutathione, or glutathione, vitamin C and NAC therapy.

Interventions

  • DRUG placebo
  • DRUG glutathione
  • DRUG glutathione, vit C and NAC

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2009-04
Est. Completion 2012-09
Phase NA

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT00889538

The ClinicalTrials.gov registry entry for NCT00889538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.

NCT00889538 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00889538 about?

NCT00889538 is a clinical study titled "Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems". This is a double-blind, placebo-controlled crossover study to evaluate the safety and efficacy of glutathione alone or glutathione, vitamin C and NAC treatment in children with autism who also have severe behavior problems. The investigators hypothesis is that children with autism will show improvem...

What is the current status of trial NCT00889538?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2009-04. Estimated completion is 2012-09.

What interventions are being tested in trial NCT00889538?

The interventions under investigation include: placebo (DRUG), glutathione (DRUG), glutathione, vit C and NAC (DRUG).

Who is sponsoring clinical trial NCT00889538?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.